Christine Reilly

654 total citations
14 papers, 405 citations indexed

About

Christine Reilly is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Oncology. According to data from OpenAlex, Christine Reilly has authored 14 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cellular and Molecular Neuroscience, 6 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Christine Reilly's work include Axon Guidance and Neuronal Signaling (11 papers), Angiogenesis and VEGF in Cancer (4 papers) and Phagocytosis and Immune Regulation (2 papers). Christine Reilly is often cited by papers focused on Axon Guidance and Neuronal Signaling (11 papers), Angiogenesis and VEGF in Cancer (4 papers) and Phagocytosis and Immune Regulation (2 papers). Christine Reilly collaborates with scholars based in United States and United Kingdom. Christine Reilly's co-authors include Maurice Zauderer, Ernest Smith, Terrence L. Fisher, Laurie A. Winter, Crystal Mallow, John E. Leonard, Alan S. Jonason, Mark Paris, Holm Bußler and Sebold Torno and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Christine Reilly

13 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christine Reilly United States	9	216	145	120	65	38	14	405
Elizabeth E. Evans United States	10	136 0.6×	159 1.1×	113 0.9×	119 1.8×	37 1.0×	31	390
Marta González-García Spain	6	90 0.4×	311 2.1×	82 0.7×	86 1.3×	23 0.6×	11	452
Claudiu Diaconu United States	7	129 0.6×	227 1.6×	23 0.2×	46 0.7×	36 0.9×	14	514
Yujun Pan China	11	82 0.4×	146 1.0×	157 1.3×	30 0.5×	11 0.3×	16	433
Jessica Tilghman United States	8	117 0.5×	222 1.5×	22 0.2×	63 1.0×	42 1.1×	12	462
Sebold Torno United States	4	95 0.4×	68 0.5×	86 0.7×	48 0.7×	16 0.4×	5	222
Jacomijn P. Dijksterhuis Sweden	8	94 0.4×	438 3.0×	46 0.4×	52 0.8×	57 1.5×	10	574
Thomas Broggini Germany	13	64 0.3×	160 1.1×	33 0.3×	48 0.7×	53 1.4×	24	319
Reiko Kinouchi Japan	11	111 0.5×	282 1.9×	67 0.6×	20 0.3×	44 1.2×	25	638
Ashleigh Hahn United States	8	121 0.6×	127 0.9×	83 0.7×	34 0.5×	15 0.4×	13	420

Countries citing papers authored by Christine Reilly

Since Specialization

Citations

This map shows the geographic impact of Christine Reilly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine Reilly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine Reilly more than expected).

Fields of papers citing papers by Christine Reilly

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine Reilly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine Reilly. The network helps show where Christine Reilly may publish in the future.

Co-authorship network of co-authors of Christine Reilly

This figure shows the co-authorship network connecting the top 25 collaborators of Christine Reilly. A scholar is included among the top collaborators of Christine Reilly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine Reilly. Christine Reilly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Ruffin, Ayana T., Brian M. Olson, Crystal Mallow, et al.. (2023). 629 Neoadjuvant SEMA4D inhibitor pepinemab combination with nivolumab increases crosstalk between B cell and CD26^hi T cell in patients with resectable stage III melanoma. SHILAP Revista de lepidopterología. A718–A718. 1 indexed citations

Evans, Elizabeth E., Vikas Mishra, Crystal Mallow, et al.. (2022). Semaphorin 4D is upregulated in neurons of diseased brains and triggers astrocyte reactivity. Journal of Neuroinflammation. 19(1). 200–200. 21 indexed citations

Olson, Brian M., Crystal Mallow, Christine Reilly, et al.. (2022). 613 Neoadjuvant SEMA4D blockade with nivolumab alters suppressive myeloid cells while elevating B cell and CD26^hi T cell infiltration in the tumors of patients with resectable stage III melanoma. Regular and Young Investigator Award Abstracts. A645–A645.

Lowe, Michael, Brian M. Olson, Anthony P. Martinez, et al.. (2020). Integrated biomarker study of neoadjuvant pepinemab and nivolumab in patients with resectable metastatic melanoma.. Journal of Clinical Oncology. 38(15_suppl). 10061–10061. 2 indexed citations

Reilly, Christine, et al.. (2018). Volume Multi-Sphere-Model Development Using Electric Field Matching. The Journal of the Astronautical Sciences. 65(4). 377–399. 8 indexed citations

LaGanke, Christopher, Lawrence Samkoff, Keith R. Edwards, et al.. (2017). Safety/tolerability of the anti-semaphorin 4D antibody VX15/2503 in a randomized phase 1 trial. Neurology Neuroimmunology & Neuroinflammation. 4(4). e367–e367. 48 indexed citations

Patnaik, Amita, Glen J. Weiss, John E. Leonard, et al.. (2015). Safety, Pharmacokinetics, and Pharmacodynamics of a Humanized Anti-Semaphorin 4D Antibody, in a First-In-Human Study of Patients with Advanced Solid Tumors. Clinical Cancer Research. 22(4). 827–836. 50 indexed citations

Leonard, John E., Terrence L. Fisher, Laurie A. Winter, et al.. (2015). Nonclinical Safety Evaluation of VX15/2503, a Humanized IgG4 Anti-SEMA4D Antibody. Molecular Cancer Therapeutics. 14(4). 964–972. 31 indexed citations

Evans, Elizabeth E., Alan S. Jonason, Holm Bußler, et al.. (2015). Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies. Cancer Immunology Research. 3(6). 689–701. 88 indexed citations

10.

Fisher, Terrence L., Christine Reilly, Virginia Litwin, et al.. (2015). Saturation monitoring of VX15/2503, a novel semaphorin 4D‐specific antibody, in clinical trials. Cytometry Part B Clinical Cytometry. 90(2). 199–208. 22 indexed citations

11.

Fisher, Terrence L., Christine Reilly, Laurie A. Winter, et al.. (2015). Generation and preclinical characterization of an antibody specific for SEMA4D. mAbs. 8(1). 150–162. 36 indexed citations

12.

Klimatcheva, Ekaterina, Christine Reilly, Sebold Torno, et al.. (2015). CXCL13 antibody for the treatment of autoimmune disorders. BMC Immunology. 16(1). 6–6. 94 indexed citations

13.

Evans, Elizabeth E., Siwen Hu‐Lieskovan, Holm Bußler, et al.. (2015). Antibody blockade of semaphorin 4D breaks down barriers to enhance tumoricidal immune infiltration and supports rational immunotherapy combinations. Journal for ImmunoTherapy of Cancer. 3(S2). 3 indexed citations

14.

Evans, Elizabeth E., Alan S. Jonason, Mark Paris, et al.. (2013). Abstract 1245: Reduction of tumor growth and metastasis by a humanized IgG4 monoclonal antibody to SEMA4D (VX15/2503).. Cancer Research. 73(8_Supplement). 1245–1245. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact